Sarepta Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
CEODouglas S. Ingram
CEODouglas S. Ingram
Employees1,314
Employees1,314
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1980
Founded1980
Employees1,314
Employees1,314
SRPT Key Statistics
Market cap12.33B
Market cap12.33B
Price-Earnings ratio-21.15
Price-Earnings ratio-21.15
Dividend yield—
Dividend yield—
Average volume638.10K
Average volume638.10K
High today$131.16
High today$131.16
Low today$127.83
Low today$127.83
Open price$131.16
Open price$131.16
Volume786.42K
Volume786.42K
52 Week high$159.89
52 Week high$159.89
52 Week low$55.25
52 Week low$55.25
SRPT News
Yahoo Finance 3d
A Comprehensive Look at Sarepta's Growth and Innovation - Yahoo FinanceSarepta Therapeutics, Inc. (NASDAQ:SRPT) is an American pharmaceutical company leading the global Duchenne muscular dystrophy, or DMD, treatment market. The co...
Simply Wall St 5d
We Might See A Profit From Sarepta Therapeutics, Inc. Soon - Simply Wall StWe feel now is a pretty good time to analyse Sarepta Therapeutics, Inc.'s ( ) business as it appears the company may be on the cusp of a considerable accomplish...
Analyst ratings
83%
of 23 ratingsBuy
82.6%
Hold
17.4%
Sell
0%